Search for: "Wyeth Pharmaceuticals"
Results 341 - 360
of 976
Sort by Relevance
|
Sort by Date
29 Jun 2011, 3:17 am
" The New York Times explained, "Two years ago, in Wyeth v. [read post]
29 Jun 2011, 3:12 am
” The New York Times explained, “Two years ago, in Wyeth v. [read post]
27 Jun 2011, 2:24 pm
The main issue in both the Wyeth and the Pliva pharmaceutical cases involved an FDA regulation referred to as "changes being effected" (CBE). [read post]
24 Jun 2011, 5:20 am
Tags: FDA, hospitals, pharmaceuticals Related posts Widespread shortages of hospital drugs (8) Hospital drug shortages, cont’d (11) Wyeth v. [read post]
23 Jun 2011, 9:23 am
See Wyeth, supra, at 573. [read post]
22 Jun 2011, 7:09 am
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
17 Jun 2011, 5:10 am
Wyeth Pharmaceuticals, No. 5:04-cv-01762 (W.D. [read post]
16 Jun 2011, 10:05 pm
Tags: hospitals, pharmaceuticals, WO writings Related posts Widespread shortages of hospital drugs (8) June 8 roundup (2) Hospital drug shortages, cont’d (11) Wyeth v. [read post]
16 Jun 2011, 12:58 pm
Wyeth, 705 S.E.2d 828 (W. [read post]
13 Jun 2011, 12:10 pm
Wyeth Pharmaceuticals, No. [read post]
9 Jun 2011, 10:02 am
Many courts have declined to find proximate causation in pharmaceutical failure-to-warn suits when the patient (or the prescribing physician if the learned intermediary doctrine is applicable) did not read the defendant manufacturer’s allegedly inadequate warning. [read post]
4 Jun 2011, 6:12 am
Tags: Henry Waxman, obstetrics, pharmaceuticals Related posts Wyeth v. [read post]
2 Jun 2011, 12:46 pm
Wyeth Inc., 488 F. [read post]
1 Jun 2011, 11:56 am
Wyeth-Ayerst Labs. [read post]
1 Jun 2011, 7:47 am
On May 19, dismissal (2010-1 Trade Cases ¶76,988) of a challenge to the 2009 merger of pharmaceutical companies Pfizer Inc. and Wyeth was affirmed. [read post]
19 May 2011, 1:15 pm
Wyeth-Ayerst Laboratories Co., 278 F. [read post]
18 May 2011, 12:33 am
Sun Pharmaceuticals on question of obviousness-type double patenting (Patent Docs) (IPBiz) Glumetza (Metformin) – US: Depomed receives notice of Para IV certification against patents from second ANDA filer, Sun Pharmaceutical (GenericsWeb) Myfortic7 (Mycophenolate) – US: Novartis files patent infringement complaint against Teva in response to Para IV certification filing (Patent Docs) NuvaRing (Etonogestrel, Estradiol) – US: ALJ Luckern sets procedural schedule in… [read post]
15 May 2011, 8:31 pm
The practice was made apparent in details of a class-action lawsuit involving the safety of drugs produced by Wyeth. [read post]
10 May 2011, 11:59 pm
" One senior official for an Indian pharmaceutical company that previously reached a settlement with Wyeth has said, “Given the large number of generic firms that had challenged the patents of Wyeth over Effexor and the series of settlements Wyeth had entered into, the average settlement amount is insignificant, mostly slightly over the litigation charges incurred by the drug firms. [read post]
5 May 2011, 11:08 pm
The various plaintiffs in the case have filed their lawsuits against the brand name makers of Reglan, Wyeth and Schwarz Pharma, as well as the makers of the generic versions like Teva Pharmaceuticals and Pliva Inc. [read post]
